Combating Cancer 2016

While cancer – in its numerous iterations – is among the most feared medical diagnoses, associated treatments have vastly improved in recent years, including progress in areas such as imaging, radiation, surgery and biopharmaceuticals. Overall, the past two decades have statistically yielded an approximate 25 percent increase in survival rates for all cancers, often with reduced treatment side effects for patients.

In the following special section, New Jersey Business magazine explores how our state’s healthcare facilities, biotechnology firms, pharmaceutical companies and research institutions are not only creating powerful synergies for combating cancer today, but are simultaneously paving the way for even better cancer care in the future.